Matches in SemOpenAlex for { <https://semopenalex.org/work/W3214104920> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W3214104920 abstract "<p class=abstract><strong>Background:</strong> Psoriasis is a disease of systemic inflammation with multiple organ ramifications. It is a chronic, painful, non-communicable, immune-mediated, genetic disease-causing disfiguration and disability, for which there is no cure and with great negative impact on patients’ quality of life (QoL). Aim and objective was to assess the efficacy and safety of adalimumab (ADA) in moderate to severe plaque psoriasis.</p><p class=abstract><strong>Methods:</strong> A hospital based, analytical retrospective observational study was conducted among patients aged 18 years and above, irrespective of gender and who received adalimumab treatment for moderate-to-severe plaque psoriasis and attended the outpatient clinic of dermatology at a tertiary care hospital for a period of 12 months. Efficacy was evaluated in all patients at 4, 12 and at last visit by calculating PASI (psoriasis area and severity index) relative to pre-treatment visit (baseline 0 week) as there was no comparative group. Safety was assessed by recording of side effects if any. Data was entered in MS excel 2019 and statistical analysis was done using SPSS 23 demo version.<strong></strong></p><p class=abstract><strong>Results:</strong> The mean PASI score at 0 week was 24.4±3.26, this when compared to PASI score at 4 weeks (11.2±4.08), at 12 weeks (3.2±2.40), at 52 weeks (0.5±0.96) had shown an extreme statistically significant difference. Side effects reported were urticaria, diarrhea, upper respiratory tract infections.</p><p class=abstract><strong>Conclusions:</strong> Adalimumab was very effective for chronic psoriasis, when given at high loading dose followed by maintenance dose every other week with minimal side effects.</p><p class=abstract> </p><p align=left> </p>" @default.
- W3214104920 created "2021-11-22" @default.
- W3214104920 creator A5021587768 @default.
- W3214104920 creator A5029783341 @default.
- W3214104920 creator A5062829930 @default.
- W3214104920 date "2021-11-04" @default.
- W3214104920 modified "2023-10-18" @default.
- W3214104920 title "Efficacy and safety of adalimumab in treating patients with moderate to severe plaque psoriasis: a retrospective study" @default.
- W3214104920 doi "https://doi.org/10.18203/issn.2455-4529.intjresdermatol20214443" @default.
- W3214104920 hasPublicationYear "2021" @default.
- W3214104920 type Work @default.
- W3214104920 sameAs 3214104920 @default.
- W3214104920 citedByCount "0" @default.
- W3214104920 crossrefType "journal-article" @default.
- W3214104920 hasAuthorship W3214104920A5021587768 @default.
- W3214104920 hasAuthorship W3214104920A5029783341 @default.
- W3214104920 hasAuthorship W3214104920A5062829930 @default.
- W3214104920 hasBestOaLocation W32141049201 @default.
- W3214104920 hasConcept C126322002 @default.
- W3214104920 hasConcept C159110408 @default.
- W3214104920 hasConcept C16005928 @default.
- W3214104920 hasConcept C167135981 @default.
- W3214104920 hasConcept C197934379 @default.
- W3214104920 hasConcept C23131810 @default.
- W3214104920 hasConcept C2777011040 @default.
- W3214104920 hasConcept C2779134260 @default.
- W3214104920 hasConcept C2779951463 @default.
- W3214104920 hasConcept C2780132546 @default.
- W3214104920 hasConcept C2780564577 @default.
- W3214104920 hasConcept C3020110884 @default.
- W3214104920 hasConcept C3020604521 @default.
- W3214104920 hasConcept C71924100 @default.
- W3214104920 hasConceptScore W3214104920C126322002 @default.
- W3214104920 hasConceptScore W3214104920C159110408 @default.
- W3214104920 hasConceptScore W3214104920C16005928 @default.
- W3214104920 hasConceptScore W3214104920C167135981 @default.
- W3214104920 hasConceptScore W3214104920C197934379 @default.
- W3214104920 hasConceptScore W3214104920C23131810 @default.
- W3214104920 hasConceptScore W3214104920C2777011040 @default.
- W3214104920 hasConceptScore W3214104920C2779134260 @default.
- W3214104920 hasConceptScore W3214104920C2779951463 @default.
- W3214104920 hasConceptScore W3214104920C2780132546 @default.
- W3214104920 hasConceptScore W3214104920C2780564577 @default.
- W3214104920 hasConceptScore W3214104920C3020110884 @default.
- W3214104920 hasConceptScore W3214104920C3020604521 @default.
- W3214104920 hasConceptScore W3214104920C71924100 @default.
- W3214104920 hasLocation W32141049201 @default.
- W3214104920 hasOpenAccess W3214104920 @default.
- W3214104920 hasPrimaryLocation W32141049201 @default.
- W3214104920 hasRelatedWork W1451534462 @default.
- W3214104920 hasRelatedWork W1608594180 @default.
- W3214104920 hasRelatedWork W2051118349 @default.
- W3214104920 hasRelatedWork W2766130161 @default.
- W3214104920 hasRelatedWork W2793564922 @default.
- W3214104920 hasRelatedWork W2803266532 @default.
- W3214104920 hasRelatedWork W2803852317 @default.
- W3214104920 hasRelatedWork W2923741572 @default.
- W3214104920 hasRelatedWork W3020955587 @default.
- W3214104920 hasRelatedWork W80953640 @default.
- W3214104920 isParatext "false" @default.
- W3214104920 isRetracted "false" @default.
- W3214104920 magId "3214104920" @default.
- W3214104920 workType "article" @default.